Author(s): Sommer C, Petrausch S, Lindenlaub T, Toyka KV
We investigated whether interleukin-1 (IL-1), a mediator of inflammatory pain, also plays a role in pain induced by nerve injury. Female C57BL/6-mice with a chronic constrictive injury of one sciatic nerve, an established model of neurogenic hyperalgesia and allodynia, were treated with different doses (10-80 microg) of a neutralizing monoclonal rat antibody to IL-1 receptor I (anti-IL-1RI). This antibody dose-dependently reduced thermal hyperalgesia and mechanical allodynia in the animals. Furthermore, immunoreactivity for the proinflammatory cytokine tumor necrosis factor-alpha (TNF) was reduced in mice treated with the highest dose of anti-IL-1RI. Degeneration of myelinated fibers was not altered by any of the treatment schedules. We conclude that IL-1 may be a mediator of hyperalgesia after nerve lesion.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/10454137
Author(s): Saroyan JM, Winfree CJ, Schechter WS, Roye D, Gold AP
Author(s): TuranIlica A, Yasar E, Tuba Sanal H, Duran C, Guvenc I
Author(s): Omezzine SJ, Zaara B, Ben Ali M, Abid F, Sassi N, et al.
Author(s): Eker HE, Cok OY, Aribogan A
Author(s): Gauthier L, Allen D, Kim P
Author(s): Lohana P, Woodnutt DJ, Boyce DE
Author(s): Bistolfi A, Massazza G, Deledda D, Lioce E, Crova M
Author(s): Dubil EA, Dahle JM, Owens MD
Author(s): Wall PD, Devor M, Inbal R, Scadding JW, Schonfeld D, et al.
Author(s): Malmberg AB, Basbaum AI
Author(s): Kiso T, Watabiki T, Tsukamoto M, Okabe M, Kagami M, et al.
Author(s): Bourquin AF, Süveges M, Pertin M, Gilliard N, Sardy S, et al.
Author(s): EDDS MV Jr, SMALL WT
Author(s): Palecek J, Dougherty PM, Kim SH, Palecková V, Lekan H, et al.
Author(s): Carlton SM, Lekan HA, Kim SH, Chung JM
Author(s): Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, et al.
Author(s): Ross KS, Marcri FJ
Author(s): Bito LZ, DeRousseau CJ, Kaufman PL, Bito JW
Author(s): Thomas J, Carver M, Haisch C, Thomas F, Welch J, et al.